Articles
EPR Academy, Part 2 of 6: The EPR Process – From Request to Reexamination Certificate
December 5, 2025
IP Updates
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Never miss an Insight.
Sign upArticles
A Look at Ex Parte Seizures 8 Years Post-DTSA A Look at Ex Parte Seizures 8 Years Post-DTSA
April 17, 2024
Law360Articles
Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation
May 1, 2023
Bloomberg LawAt the PTAB Blog
Moderna’s Appeal of PTAB Decision Dismissed for Lack of Standing Moderna’s Appeal of PTAB Decision Dismissed for Lack of Standing
December 20, 2021
Articles
Ex Parte Seizure Under the Defend Trade Secrets Act: Insights on the New Remedy Ex Parte Seizure Under the Defend Trade Secrets Act: Insights on the New Remedy
April 8, 2020
Westlaw Journal Intellectual PropertyArticles
Three Years Later: How the Defend Trade Secrets Act Complicated the Law Instead of Making It More Uniform Three Years Later: How the Defend Trade Secrets Act Complicated the Law Instead of Making It More Uniform
July/August 2019
IP LitigatorBooks
Coordinating New Drug Application (NDA) and Patent Portfolio Strategy Coordinating New Drug Application (NDA) and Patent Portfolio Strategy
2018
Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, Second EditionArticles
Impermissibly Redefining 'Long-Felt Need' Using Hindsight Impermissibly Redefining 'Long-Felt Need' Using Hindsight
March 2, 2018
Law360Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.